Global Lyme Disease Diagnostic Devices Market Size, Trends, and Growth Opportunity, By Product Type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test, Immunofluorescent Staining, and Nucleic acid Test), By End User (Hospitals, Public/Private Laboratories, and Physician’s Office), By Region and Forecast to 2030.
Global Lyme Disease Diagnostic Devices Market 
The Global Lyme Disease Diagnostic Devices Market was valued at USD 2.78 billion in 2022 and is expected to reach USD 4.89 billion by 2030, at a CAGR 7.31% during the forecast period 2023- 2030.
The bacterium species borrelia is the cause of Lyme disease. It typically spreads among humans through the bite of infected ticks. Depression, fever, exhaustion, and rashes are among the symptoms experienced by Lyme disease patients. Antibiotics can be used to treat the sickness if it is discovered early on. Yet, if the condition is not addressed, it can harm the heart, joints, and central nervous system and even result in death.
Market Drivers
The rise in Lyme disease prevalence, a supportive government towards healthcare facilities, and the appearance of new Lyme diagnostic tests are anticipated to drive market growth during the forecast period. Also, the market for Lyme disease diagnostics is expanding due to the rise in tick-borne disease cases. For instance, the Centers for Disease Control and Prevention recorded 47,743 cases of tick-borne infections in 2021, which prompted the development of Lyme disease diagnostic tests.
Market Restraints
Lack of knowledge about the illness and ineffective Lyme disease testing severely is anticipated to hamper the market growth during the forecast period.
COVID 19 Impacts
Healthcare professionals' focus has been diverted by the global COVID-19 epidemic, which is harming all facets of medical and diagnostic treatment. Several indirect health repercussions of the crisis have also been observed. As the coronavirus spread and started to take over the world, people with Lyme disease symptoms were asked to postpone their tests. Furthermore, non-specific flu-like symptoms including fever, headache, and general achiness and exhaustion frequently precede the characteristic symptoms of Lyme and COVID-19 viruses, raising concerns among patients and medical professionals concerning both illnesses. Patients were advised to diagnose additional ailments with the assistance of accessible medical institutes.
Market Segmentation
The Global Lyme Disease Diagnostic Devices Market is segmented into Product Type and End User.
Based on Product Type, the market is divided into Serological Tests, Urine Antigen Tests, Lymphocytic Transformation tests, Immunofluorescent Staining, and Nucleic acid Tests.
Based on End User, the market is classified into Hospitals, Public/Private Laboratories, and Physician’s Office.
Regional Analysis
 The Global Lyme Disease Diagnostic Devices Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
North America is anticipated to account for a sizeable market share in the global market for Lyme disease diagnostics. This can be ascribed to the rising incidence of diseases transmitted by ticks and the expansion of government and commercial initiatives for the diagnosis of Lyme disease in this area. For instance, the Centers for Disease Control and Prevention (CDC) reported in 2021 that each year in North America, about 300,000 people received a Lyme disease diagnosis. 
Furthermore, rising healthcare costs and the availability of well-established healthcare infrastructure are both significantly contributing to the growth of the regional industry as a whole. To find the pathogens that cause Lyme infections, several significant important market participants in the area have increased their portfolios of Lyme disease diagnostics.
Key Players
Various key players are discussed in the Global Lyme Disease Diagnostic Devices Market Report including: Abbott Laboratories, T2 Biosystems, Canon Life Sciences, Bio-Rad Laboratories, Alere Inc., Roche Diagnostics International Ltd., Graphene Frontiers, Covance Inc., Immunetics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Boulder Diagnostics.
In July 2022, T2Biosystems, T2Lyme Panel received approval from the US Food and Drug Administration. The T2Lyme Panel is intended to enable more precise early Lyme disease diagnosis, which may help to enhance care and improve patient outcomes. The T2Lyme Panel uses a patient's blood to identify the germs that cause Lyme disease. 
Market Taxonomy
By Product Type 
• Serological Test
• Urine Antigen Tests
• Lymphocytic Transformation Test
• Immunofluorescent Staining
• Nucleic acid Test
By End User 
• Hospitals
• Public/Private Laboratories
• Physician’s Office
By Region
• North America 
• Latin America 
• Europe  
• Asia Pacific  
• Middle East & Africa

Global Lyme Disease Diagnostic Devices Market 
1 Introduction 
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Lyme Disease Diagnostic Devices Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn 
4.2.6 Post covid-19 world Supply & Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Lyme Disease Diagnostic Devices Market, By Product Type
5.1 Y-o-Y Growth Comparison, By Product Type
5.2 Global Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type
5.3 Global Lyme Disease Diagnostic Devices Market Size and Forecast, By Product Type
5.3.1 Serological Test
5.3.2 Urine Antigen Tests 
5.3.3 Lymphocytic Transformation Test
5.3.4 Immunofluorescent Staining
5.3.5 Nucleic acid Test
6 Global Lyme Disease Diagnostic Devices Market, By End User
6.1 Y-o-Y Growth Comparison, By End User
6.2 Global Lyme Disease Diagnostic Devices Market Share Analysis, By End User
6.3 Global Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
6.3.1 Hospitals
6.3.2 Public/Private Laboratories
6.3.3 Physician’s Office
7 Global Lyme Disease Diagnostic Devices Market, By Region
7.1 Global Lyme Disease Diagnostic Devices Market Share Analysis, By Region
7.2 Global Lyme Disease Diagnostic Devices Market Size and Forecast, By Region
8 North America Global Lyme Disease Diagnostic Devices Market Analysis and Forecast (2023-2030)
8.1 Introduction
8.2 North America Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type
8.3 North America Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
8.4 North America Lyme Disease Diagnostic Devices Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9 Europe Global Lyme Disease Diagnostic Devices Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 Europe Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type 
9.3 Europe Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
9.4 Europe Lyme Disease Diagnostic Devices Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4 Rest of Europe
10 Asia Pacific Lyme Disease Diagnostic Devices Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Asia Pacific Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type   
10.3 Asia Pacific Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
10.4 Asia Pacific Lyme Disease Diagnostic Devices Market Size and Forecast, By Country
10.4.1 China 
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
11 Latin America Global Lyme Disease Diagnostic Devices Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Latin America Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type  
11.3 Latin America Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
11.4 Latin America Lyme Disease Diagnostic Devices Market Size and Forecast, Country
11.4.1 Brazil
11.4.2 Rest of Latin America
12 Middle East Global Lyme Disease Diagnostic Devices Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Middle East Lyme Disease Diagnostic Devices Market Share Analysis, By Product Type  
12.3 Middle East Lyme Disease Diagnostic Devices Market Size and Forecast, By End User
12.4 Middle East Lyme Disease Diagnostic Devices Market Size and Forecast, By Country
12.4.1 Saudi Arabia
12.4.2 UAE
12.4.3 Egypt
15.4.4 Kuwait
12.4.5 South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 Abbott Laboratories
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 T2 Biosystems
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Canon Life Sciences
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Bio-Rad Laboratories
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Alere Inc.
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Roche Diagnostics International Ltd.
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Graphene Frontiers 
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies 
14.8 Covance Inc.
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Immunetics Inc.
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies